These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 19893453
1. Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines. Han F, Gu D, Chen Q, Zhu H. Pancreas; 2009 Oct; 38(7):766-74. PubMed ID: 19893453 [Abstract] [Full Text] [Related]
2. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway. Gu D, Li H, Wang Z, Chen Q, Jiang J, Zhu H. Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498 [Abstract] [Full Text] [Related]
3. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer. Younes MN, Yazici YD, Kim S, Jasser SA, El-Naggar AK, Myers JN. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3425-34. PubMed ID: 16740767 [Abstract] [Full Text] [Related]
4. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A. Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576 [Abstract] [Full Text] [Related]
5. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J. Clin Cancer Res; 2005 Apr 01; 11(7):2702-12. PubMed ID: 15814652 [Abstract] [Full Text] [Related]
6. [Over-expression of caveolin-1 inhibits proliferation and invasion of pancreatic carcinoma cells in vitro]. Han F, Zhu HG. Zhonghua Zhong Liu Za Zhi; 2009 Oct 01; 31(10):732-7. PubMed ID: 20021823 [Abstract] [Full Text] [Related]
7. SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. Shang C, Guo Y, Fu S, Fu W, Sun K. Med Sci Monit; 2010 Jun 01; 16(6):BR168-73. PubMed ID: 20512084 [Abstract] [Full Text] [Related]
8. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219 [Abstract] [Full Text] [Related]
9. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS. J Pharmacol Exp Ther; 2008 Jun 01; 325(3):841-9. PubMed ID: 18337475 [Abstract] [Full Text] [Related]
10. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Fiucci G, Ravid D, Reich R, Liscovitch M. Oncogene; 2002 Apr 04; 21(15):2365-75. PubMed ID: 11948420 [Abstract] [Full Text] [Related]
11. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown. Huang WC, Hsu RM, Chi LM, Leu YL, Chang YS, Yu JS. Cancer Lett; 2007 Apr 08; 248(1):137-46. PubMed ID: 16919867 [Abstract] [Full Text] [Related]
12. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, Teh BT. Cancer Res; 2008 Jan 01; 68(1):81-8. PubMed ID: 18172299 [Abstract] [Full Text] [Related]
13. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner. Liu ZB, Hou YF, Zhu J, Hu DL, Jin W, Ou ZL, Di GH, Wu J, Shen ZZ, Shao ZM. Oncogene; 2010 May 20; 29(20):2996-3009. PubMed ID: 20228837 [Abstract] [Full Text] [Related]
14. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. Sawai H, Okada Y, Kazanjian K, Kim J, Hasan S, Hines OJ, Reber HA, Hoon DS, Eibl G. Cancer Res; 2005 Dec 15; 65(24):11536-44. PubMed ID: 16357163 [Abstract] [Full Text] [Related]
15. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells. Yoshida J, Ishibashi T, Yang M, Nishio M. Life Sci; 2010 Jan 16; 86(3-4):124-32. PubMed ID: 19951711 [Abstract] [Full Text] [Related]
16. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM. Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629 [Abstract] [Full Text] [Related]
17. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094 [Abstract] [Full Text] [Related]
18. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein. Davoodpour P, Landström M, Welsh M. BMC Cancer; 2007 Aug 15; 7():161. PubMed ID: 17697368 [Abstract] [Full Text] [Related]
19. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. Takeuchi K, Shin-ya T, Nishio K, Ito F. FEBS J; 2009 Mar 15; 276(5):1255-65. PubMed ID: 19175673 [Abstract] [Full Text] [Related]
20. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Liu Y, Poon RT, Shao W, Sun X, Chen H, Kok TW, Fan ST. Cancer Lett; 2007 Apr 08; 248(1):32-40. PubMed ID: 16837130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]